To examine the long‐term oncological outcomes and urological morbidity of low‐dose‐rate prostate brachytherapy (LDRBT) monotherapy using live intraoperative dosimetry planning and an automated needle navigation delivery system for the treatment… Click to show full abstract
To examine the long‐term oncological outcomes and urological morbidity of low‐dose‐rate prostate brachytherapy (LDRBT) monotherapy using live intraoperative dosimetry planning and an automated needle navigation delivery system for the treatment of men with low and intermediate‐risk prostate cancer.
               
Click one of the above tabs to view related content.